Estimating the prevalence of AATD patients potentially eligible for augmentation therapy in the UK on the basis of symptomatic COPD - *Open for dissemination costs only*
Estimating the prevalence of AATD patients potentially eligible for augmentation therapy in the UK on the basis of symptomatic COPD - *Open for dissemination costs only*